GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » Other Long Term Assets

ValiRx (LSE:VAL) Other Long Term Assets : £0.03 Mil (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is ValiRx Other Long Term Assets?

ValiRx's other long-term assets for the quarter that ended in Dec. 2024 was £0.03 Mil.

ValiRx's quarterly other long-term assets increased from Dec. 2023 (£-0.00 Mil) to Jun. 2024 (£0.03 Mil) and increased from Jun. 2024 (£0.03 Mil) to Dec. 2024 (£0.03 Mil).

ValiRx's annual other long-term assets declined from Dec. 2022 (£0.00 Mil) to Dec. 2023 (£-0.00 Mil) but then increased from Dec. 2023 (£-0.00 Mil) to Dec. 2024 (£0.03 Mil).

ValiRx Other Long Term Assets Historical Data

The historical data trend for ValiRx's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ValiRx Other Long Term Assets Chart

ValiRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.03

ValiRx Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.03 0.03

ValiRx Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

ValiRx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » Other Long Term Assets
Comparable Companies
LSE:ROQ LSE:NFX LSE:BSFA LSE:PYC LSE:GENF LSE:OVB LSE:TCF AQSE:INC LSE:CIZ LSE:APTA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
EAJF:Germany
Address
D6 Thane Road, MediCity Nottingham, Nottingham, GBR, NG90 6BH
Website
https://www.valirx.com
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, VAL401 for lung cancer, VAL301, BC201, CLX001, and other drug candidates in their different stages of development.